Rigel Pharmaceuticals, Inc.’s RIGL share price has dipped by 10.05%, which has investors questioning if this is right time to ...
David A. Santos, Executive Vice President and Chief Commercial Officer at Rigel Pharmaceuticals Inc. (NASDAQ:RIGL), recently sold a portion of his holdings in the company. According to a recent SEC ...
Zacks.com on MSN5d
Does Rigel (RIGL) Have the Potential to Rally 40.88% as Wall Street Analysts Expect?The mean of analysts' price targets for Rigel (RIGL) points to a 40.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts ...
J. Furey, the Executive Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary at Rigel Pharmaceuticals Inc. (NASDAQ:RIGL), recently sold shares of the company's common ...
Implementing environmental, social, and governance (ESG) practices has become a non-negotiable prerequisite for any business ...
5086 Arabella Cir: Wp Summit Park LLC to Pickens Sandra; $265,000 5090 Arabella Cir: Wp Summit Park LLC to Gruesser Bob & ...
Implementing environmental, social, and governance (ESG) practices has become a non-negotiable prerequisite for any business ...
Watch a bright Moon dominate the sky, trace the Winter Hexagon, and continue enjoying the evening parade of planets in the ...
OHEP has seen a surge in applications and calls for assistance since the recent BGE rate increases. Last year, the program ...
Towards the end of the month, Mercury appears in the evening sky, and climbs up past Saturn. In the dusk glow, you may be ...
From planets and constellations, to eclipses and the Aurora Borealis, here's what to look for in the sky this spring ...
Almost a year to the day after Roche pulled out a partnership on its underperforming cancer therapy Gavreto, Blueprint Medicines has sold US commercial rights to the drug to Rigel Pharma in a deal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback